ArticleNature cardiovascular research2023

Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine.

Michael Lenaeus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.